tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
CG Oncology resumed with a Buy at Goldman Sachs
PremiumThe FlyCG Oncology resumed with a Buy at Goldman Sachs
29d ago
CG Oncology price target raised to $56 from $52 at Morgan Stanley
Premium
The Fly
CG Oncology price target raised to $56 from $52 at Morgan Stanley
2M ago
Premium
Company Announcements
CG Oncology Holds 2025 Annual Stockholders Meeting
2M ago
PremiumRatingsPromising Prospects for CG Oncology’s Cretostimogene in NMIBC Treatment: Superior Efficacy and Strategic Expansion
3M ago
CG Oncology reports Q1 EPS (45c), consensus (37c)
Premium
The Fly
CG Oncology reports Q1 EPS (45c), consensus (37c)
3M ago
Apple downgraded, Reddit upgraded: Wall Street’s top analyst calls
Premium
The Fly
Apple downgraded, Reddit upgraded: Wall Street’s top analyst calls
3M ago
PremiumCompany AnnouncementsCG Oncology Announces Promising Phase 3 Trial Results
3M ago
Premium
Ratings
Promising Potential of CG Oncology’s Cretostimogene: A Buy Rating Justified by Superior Performance and Safety Profile
3M ago
Premium
Ratings
Buy Rating for CG Oncology, Inc. Driven by Promising Therapeutic Developments and Strong Safety Profile of Creto
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100